Drugs / DA-5222
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07046715 | Jul → Aug 2025 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT06993181 | Jun → Jul 2025 overdue | — | Dong-A ST Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT06993168 | May → Jul 2025 overdue | — | Dong-A ST Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-5222 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07046715 ↗ |